# Initial Experience With Spatial Resynchronization Therapy in Patients With Atrial Fibrillation

> **NCT05461612** · NA · UNKNOWN · sponsor: **Maxwell Biomedical** · enrollment: 30 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** Spatial Resynchronization Therapy delivered by the MAX-SRS, external recording and stimulation device

## Key facts

- **NCT ID:** NCT05461612
- **Lead sponsor:** Maxwell Biomedical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-23
- **Primary completion:** 2023-06
- **Final completion:** 2023-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05461612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05461612, "Initial Experience With Spatial Resynchronization Therapy in Patients With Atrial Fibrillation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05461612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*